A Ueki

979 total citations
33 papers, 770 citations indexed

About

A Ueki is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, A Ueki has authored 33 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in A Ueki's work include Occupational and environmental lung diseases (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). A Ueki is often cited by papers focused on Occupational and environmental lung diseases (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). A Ueki collaborates with scholars based in Japan, Malta and Qatar. A Ueki's co-authors include Takemi Otsuki, Fuminori Hyodoh, Hiroaki Ueki, Akiko Tomokuni, Haruko Sakaguchi, Masayasu Kusaka, Yasuhiko Kawakami, Yumika Isozaki, Osamu Wada and Shigeo Manabe and has published in prestigious journals such as The Science of The Total Environment, Journal of Bacteriology and Environmental Pollution.

In The Last Decade

A Ueki

33 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Ueki Japan 17 242 233 195 97 90 33 770
Fuminori Hyodoh Japan 20 390 1.6× 322 1.4× 288 1.5× 50 0.5× 115 1.3× 53 1.1k
Keiko Komatsu Japan 13 183 0.8× 255 1.1× 88 0.5× 64 0.7× 57 0.6× 24 748
Jose L. Lepe‐Zuniga United States 13 153 0.6× 210 0.9× 340 1.7× 152 1.6× 54 0.6× 20 928
B A Fiedel United States 15 175 0.7× 277 1.2× 234 1.2× 176 1.8× 28 0.3× 37 948
Ruggiero Fumarulo Italy 17 137 0.6× 458 2.0× 172 0.9× 241 2.5× 65 0.7× 33 981
P Mahieu Belgium 18 132 0.5× 348 1.5× 264 1.4× 58 0.6× 61 0.7× 39 1.1k
Dermot Kelleher Ireland 21 117 0.5× 245 1.1× 358 1.8× 29 0.3× 89 1.0× 39 1.3k
Hsiu-san Lin United States 16 135 0.6× 162 0.7× 293 1.5× 142 1.5× 121 1.3× 29 827
M. Kent Froberg United States 16 106 0.4× 313 1.3× 58 0.3× 42 0.4× 114 1.3× 22 953
Shringi Sharma United States 14 129 0.5× 233 1.0× 100 0.5× 84 0.9× 46 0.5× 48 884

Countries citing papers authored by A Ueki

Since Specialization
Citations

This map shows the geographic impact of A Ueki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Ueki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Ueki more than expected).

Fields of papers citing papers by A Ueki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Ueki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Ueki. The network helps show where A Ueki may publish in the future.

Co-authorship network of co-authors of A Ueki

This figure shows the co-authorship network connecting the top 25 collaborators of A Ueki. A scholar is included among the top collaborators of A Ueki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Ueki. A Ueki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otsuki, Takemi, Haruko Sakaguchi, Tamayo Hatayama, et al.. (2004). Secretory Ig a in Saliva and Academic Stress. International Journal of Immunopathology and Pharmacology. 17(2_suppl). 45–48. 16 indexed citations
2.
Ueki, Hiroaki, et al.. (2001). Antidesmoglein Autoantibodies in Silicosis Patients with No Bullous Diseases. Dermatology. 202(1). 16–21. 25 indexed citations
3.
Ueki, A, Yumika Isozaki, Akiko Tomokuni, et al.. (2001). Autoantibodies detectable in the sera of silicosis patients. The relationship between the anti-topoisomerase I antibody response and HLA-DQB1 *0402 allele in Japanese silicosis patients. The Science of The Total Environment. 270(1-3). 141–148. 11 indexed citations
4.
Otsuki, Takemi, Hironobu Hata, N Harada, et al.. (2000). Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.. PubMed. 72(2). 216–22. 16 indexed citations
5.
Otsuki, Takemi, Osamu Yamada, Haruko Sakaguchi, et al.. (1998). In vitro excess ammonia production in human myeloma cell lines. Leukemia. 12(7). 1149–1158. 33 indexed citations
6.
Otsuki, Takemi, Haruko Sakaguchi, Akiko Tomokuni, et al.. (1998). Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology. 94(2). 258–262. 45 indexed citations
7.
Tomokuni, Akiko, et al.. (1998). Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro.. International Journal of Oncology. 12(6). 1355–9. 49 indexed citations
8.
Otsuki, Takemi, Takashi Sugihara, Akio Kanzaki, et al.. (1997). Multiple cerebral infarctions in a patient with refractory idiopathic thrombocytopenic purpura. Journal of Internal Medicine. 241(3). 253–256. 16 indexed citations
9.
Kishimoto, Tadamitsu, et al.. (1996). The analysis of peripheral blood lymphocytes of patients with silicosis and effects of silica in vitro. Journal of Occupational Health. 38(6). 253–257. 2 indexed citations
10.
Kishimoto, Tadamitsu, et al.. (1996). [The analysis of peripheral blood lymphocytes of patients with silicosis and effects of silica in vitro].. PubMed. 38(6). 253–7. 3 indexed citations
11.
Manabe, Shigeo, et al.. (1995). N-Methyl-β-carboline-3-carboxamide (FG 7142): An anxiogenic agent in cigarette smoke condensate and its mechanism of formation. Environmental Pollution. 89(3). 329–335. 2 indexed citations
12.
Tsushima, Hiroshi, et al.. (1994). Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology. 140(1). 167–171. 24 indexed citations
13.
Ueki, A, et al.. (1994). Polyclonal human T-cell activation by silicate in vitro.. PubMed. 82(2). 332–5. 81 indexed citations
14.
Kurihara, Nobutaka, et al.. (1993). Nucleic acids induce the formation of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in a model system. Carcinogenesis. 14(5). 903–906. 15 indexed citations
15.
Manabe, Shigeo, Hiramitsu Suzuki, Osamu Wada, & A Ueki. (1993). Detection of the carcinogen 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in beer and wine. Carcinogenesis. 14(5). 899–901. 65 indexed citations
16.
Tsushima, Hiroshi, et al.. (1992). Purification and characterization of a cystatin-type cysteine proteinase inhibitor in the human hair shaft. Archives of Dermatological Research. 284(7). 380–385. 11 indexed citations
17.
Ueki, A, Masahiro Yamaguchi, Y. Watanabe, et al.. (1992). Activation of human CD4+CD45RA+ T cells by chrysotile asbestos in vitro. Cancer Letters. 66(2). 99–106. 10 indexed citations
18.
Tsushima, Hiroshi, Fuminori Hyodoh, Erina Yoshida, A Ueki, & V. K. Hopsu‐Havu. (1992). Inactive cathepsin B-like enzyme in human melanoma culture medium. Melanoma Research. 1(5). 341–348. 5 indexed citations
19.
Hyodoh, Fuminori, et al.. (1990). Elevated binding activity of CD8+ cells with phytohaemagglutinin by asbestos fibrein vitro. Clinical & Experimental Immunology. 80(1). 89–93. 5 indexed citations
20.
Ueki, A, et al.. (1989). Distribution of phenolsulphotransferase and monoamine oxidase in the common marmoset. Biochemical Pharmacology. 38(14). 2383–2385. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026